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Abstract: Sirtuins are NAD+-dependent deacetylases and ADP ribosyltransferases that are activated under stress conditions such as
calorie restriction and starvation. Boron, which is mostly found in the form of boric acid (BA) or sodium borate (NaB), is known to
bind NAD+. In this study, the effect of NaB on hepatoma cell line HEP3B was investigated by analyzing the proteins harvested from
NaB-treated and serum-starved HEP3B cells. The NaB treatment (15 µg/mL) led to a decrease in the overall proteome acetylation
and particularly in mitochondria, the synthesis rate of respiratory complexes, the amount of cellular reactive oxygen species, and the
proliferation rate of HEP3B cells. On the other hand, the cellular ratio of NAD+/NADH and the deacetylase activity of mitochondrial
sirtuin, SIRT3, were found to be elevated. The results of this study suggest a link between boron treatment and activation of SIRT3 by
means of a NAD+–NaB interaction, which reprograms cellular metabolism. This study is expected to pave the way for new findings
uncovering the metabolic changes in HEP3B cells related to SIRT3 activity upon NaB treatment.
Key words: Boron, sodium borate, sodium pentaborate pentahydrate, calorie restriction, NAD, mitochondria, acetylation, deacetylation,
NAD+-dependent deacetylase, Warburg effect

1. Introduction
Cancer cells mostly maintain higher rates of glycolysis
by downregulating their oxidative phosphorylation
(OXPHOS) regardless of environmental oxygen
concentrations, a situation known as the Warburg effect.
Decreased OXPHOS in cells displaying the Warburg effect
is mostly associated with malfunctioning mitochondria
(Chen and Russo, 2012), which is in turn related to cellular
energy metabolism, maintained by the NAD+/NADH ratio
(Saunders and Verdin, 2007). The increased glucose uptake
related to the Warburg effect not only serves as a source of
ATP generation through the tricarboxylic acid (TCA) cycle,
but also as a source of carbon and metabolites harnessed
in the synthesis of macromolecules supporting cellular
proliferation (Huang et al., 2014). This is predominantly
seen in fast-growing tumor cells (Jose et al., 2011) such as
hepatoma, providing a growth advantage over healthy cells
as they become less exposed to oxidative stress by avoiding
high levels of reactive oxygen species (ROS) (Kondoh et al.,
2007; Sosa et al., 2013). Hepatocellular carcinoma (HCC)
is a type of liver cancer, which primarily results from viral
hepatitis B infection. Pathways related to immunity, cell
cycle, protein metabolism, translation, glycolysis, and
* Correspondence: huseyin.cimen@yeditepe.edu.tr
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OXPHOS are especially altered in HBV-induced HCC
(Lee et al., 2012). Additionally, enhanced generation and
accumulation of ROS is lethal for cells through cellular
mechanisms. This includes oxidative damage to cellular
components, which in turn affects cellular proliferation,
apoptosis, tissue invasion, and metastasis (Sosa et al.,
2013). Compared to normal cells, tumorigenic cells can
endure high levels of ROS by inducing new redox balances
within their metabolisms. In this way, cancer cells have the
capacity to survive against free radical damage through
reprogramming their metabolic rate and increasing
proliferation (Sosa et al., 2013). Mitochondria have a great
impact on tumor cell survival by mediating apoptotic
pathways (Gogvadze et al., 2008); the maintenance
of mitochondrial potential and oxidative equilibrium
controls the cell viability. Loss of structural integrity in
the mitochondrial inner membrane and disruption of
OXPHOS machinery leads to an impairment of membrane
potential (Verdin et al., 2010). Mitochondrial function
is tightly controlled by posttranslational modifications
(PTMs) such as acetylation and phosphorylation (Koc
and Koc, 2012; Newman et al., 2012; Padrao et al., 2013).
The most common and crucial type of PTM taking place
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in mitochondria is lysine acetylation, which occurs in
proteins involved in metabolic regulations (Kim et al.,
2006; Choudhary et al., 2009; Close et al., 2010; Wang et al.,
2010; Zhao et al., 2010; Hirschey et al., 2011). Sirtuins are
redox-sensitive and one of the main regulators of lifespan
in response to stress (Hubbard and Sinclair, 2014). They
regulate the acetylation state of histones, transcription
factors, and additional nonhistone protein targets
implicated in the expression of genes involved in stress
response, energy metabolism, and longevity (Suchankova
et al., 2009). Having the most robust mitochondrial
deacetylase activity, SIRT3 is the primary regulator of
lysine acetylation in mitochondria (Amado et al., 2014).
Nutrient starvation induces elevated levels of NAD+
leading to increased activity of SIRT3 and a shift away from
liver glycolysis upon calorie restriction (Brosnan, 2000).
Boron, which is one of the highly beneficial trace elements
for humans, animals, and plants, is widely distributed in
nature and is released by natural processes (Hunt and Idso,
1999). It is an active inducer of the immune system and
is known to bind to NAD+ through reactions involving
the hydroxyl groups on pyridine nucleotides (Hunt and
Idso, 1999). In this study, we have investigated how the
interaction of sodium borate (NaB) with NAD+ might alter
the intracellular NAD+/NADH ratio and affect the cellular
level of ROS and SIRT3 activity in HEP3B, an HCC cell
line.
2. Materials and methods
2.1. Cell culture and boron treatment
HEP3B, human hepatoma cells, were cultured in
Dulbecco’s modified Eagle’s medium (DMEM) (GIBCO,
Germany) in the presence of 10% (v/v) fetal bovine serum
(GIBCO) and 1% penicillin–streptomycin (GIBCO) at 37
°C and 5% CO2. The HEP3B cells were treated with NaB
(sodium pentaborate pentahydrate from Boren, Turkey) in
low-glucose (1 g/L) DMEM (GIBCO) for 72 h and starved
for serum for the last 24 h.
2.2. Protein amount measurement
Protein extraction from cells was prepared with the RIPA
lysis buffer system (Santa Cruz Biotechnology, USA)
supplemented with 2 mM PMSF, 1X protease inhibitor
cocktail, and 1 mM sodium orthovanadate (Santa Cruz
Biotechnology). Protein amounts of cell lysates were
determined using the Pierce BCA Protein Assay Kit
(Pierce Biotechnology, USA), using bovine serum albumin
as a standard.
2.3. Isolation of mitochondrial fraction
Mitochondria were isolated from HEP3B cells (8 × 107)
treated with 15 µg/mL NaB for 72 h by employing a
protocol modified from Cimen et al. (2010). Cell pellets
were resuspended in isolation buffer containing 26 mM
sucrose (Carlo Erba, Italy), 50 mM Tris-HCl (pH 7.6; MP-

Biomedicals, USA), 40 mM KCl (Merck, Germany), 20
mM MgCl2 (Merck), 0.8 mM EDTA (Merck), and 6 mM
β-mercaptoethanol (Merck), supplemented with 0.1%
(w/v) PMSF (Roche, Switzerland). After separating the
cytosolic fraction, the remaining pellets were resuspended
in wash buffer (50 mM Tris-HCl, pH 7.6; 40 mM KCl; 20
mM MgCl2; 1 mM DTT) supplemented with 0.1% (w/v)
PMSF. Pellets were obtained by centrifuging twice, at
12,000 × g and 4 °C for 10 min. Percent relative acetylation
of mitochondrial protein samples was calculated by
normalizing the obtained quantitative acetylation data.
Each quantitation was initially done using the control
sample (0 µg/mL) as a reference. The amount of acetylation
signal of each sample was then divided by the amount of
respective control signals. GAPDH mouse monoclonal
antibody (1:5000) and HSP60 mouse monoclonal antibody
(1:5000) were blotted onto the same PVDF membrane as
control antibodies.
2.4. Immunoblotting
Protein samples harvested from HEP3B cells were
loaded onto SDS-polyacrylamide gel and transferred to
a polyvinylidene difluoride membrane (PVDF). Protein
in the amount of 20 µg was loaded for each sample to be
analyzed. For acetylome profiling, the blot was probed with
an acetylated lysine monoclonal antibody (Cell Signaling,
USA) at 1:1000 dilution, glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) mouse monoclonal antibody
(Abcam, UK) at 1:5000 dilution, and heat-shock protein
60 (HSP60) mouse monoclonal antibody (Cell Signaling)
at 1:5000 dilution. Percent relative acetylation of whole-cell
lysate protein samples was calculated by normalizing the
obtained quantitative acetylation data. Each quantitation
was done initially using the control sample (0 µg/mL) as a
reference. The amount of acetylation signal of each sample
was then divided by the amount of respective control
signals. To analyze the OXPHOS enzyme complexes, the
blot was probed with Total OXPHOS Rodent WB Antibody
Cocktail (Abcam) and HSP60 mouse monoclonal antibody
(Cell Signaling) at 1:5000 dilutions. Secondary antibody
for acetylation was antirabbit IgG (Sigma-Aldrich, USA)
at 1:2500 dilution and antimouse IgG (Sigma-Aldrich)
at 1:5000 dilution for GAPDH, HSP60, and OXPHOS
profiling. Imaging was performed using the BIO-RAD
ChemiDoc XRS + Molecular Imager with Lab Software.
2.5. Intracellular NAD+/NADH ratio measurement
The intracellular NAD+/NADH ratio of NaB-treated
HEP3B cells was determined using the NAD+/NADH
Assay Kit (Abcam). The kit contains a specific enzyme mix
that creates a cyclic reaction in which the oxidized form of
nicotinamide dinucleotide, NAD+, and its reduced form,
NADH, are constantly being produced and metabolized.
The kit is designed to specifically detect NADH and
NAD, so the intracellular ratio of NAD+ to NADH can
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be calculated accordingly. HEP3B cells were cultured and
treated in 6-well plates. Cells (1.5 × 106) were harvested
for each sample and the assay was performed immediately
after a cold PBS rinse followed by application of NAD+/
NADH extraction buffer. Cellular NAD+/NADH ratio
was determined by separately measuring the NAD total
(NADt) and NADH amounts in cultured HEP3B cells
harvested after treatment with 15 µg/mL NaB for 72 h
in combination with starvation applied for the last 24 h.
NAD+/NADH ratios were then calculated using NADH
and NADt amounts. The amount of NADH was detected
at 450 nm using the BIO-TEK EL × 800 Microplate Reader.
2.6. Cell viability assay
The viability of treated cells was investigated using the
CellTiter96 Aqueous Non-Radioactive Cell Proliferation
Assay (Promega, USA). Cells (1000 per well) were
inoculated into a 96-well plate in high-glucose DMEM
media containing 10% FBS and 1% penicillin–
streptomycin. NaB treatment (15 µg/mL) in low-glucose
DMEM media containing 10% FBS and 1% penicillin–
streptomycin was initiated on day 2, prior to measurement.
Starvation in combination with 15 µg/mL NaB treatment
in serum-free low-glucose DMEM media was performed
after the measurement on day 3. For the absorbance
measurements, the BIO-TEK EL × 800 Microplate Reader
was used. Results were calculated by taking the average of
absorbance values of each sample in triplicate. Data were
normalized based on absorbance results obtained on the
initial day of the experiment.
2.7. Cellular ROS detection
Cellular ROS detection was performed in the presence of
a cell permeant reagent, 2’,7’-dichlorofluorescein diacetate
(DCFDA), using the DCFDA Cellular ROS Detection
Assay Kit (Abcam). HEP3B cells (5 × 104) treated in a
6-well plate were harvested for each sample to be analyzed
with the BD FACSCalibur Flow Cytometer at excitation
of 495 nm and emission of 529 nm. Percent decrease in
ROS level in HEP3B cells treated with 15 µg/mL NaB was
compared to nontreated cells.
2.8. SIRT3 activity assay
The effect of NaB (15 µg/mL) on SIRT3 activity was
determined using the SIRT3 Deacetylase Fluorometric
Assay Kit (CycLex, Japan). Measurements were done
using the BC BIOTEK FL × 800 TBID fluorometric
microplate reader at excitation of 460 nm and emission of
360 nm. The reaction was performed by measuring SIRT3
deacetylase activity on a fluoro-substrate peptide added
to the mixture. Specific activity of SIRT3 was calculated
using fluorescence intensity values obtained in the initial
20 min of reaction, according to the data obtained from a
fluorometric microplate reader.
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2.9. Statistical analysis
The statistical significance of each experimental result
was analyzed by running an unpaired t-test from the
averaged data obtained from 3 independent experiments
using GraphPad Software. P < 0.05 from 3 independent
experiments was taken as significant.
3. Results
3.1. NaB treatment decreases proteome acetylation
HEP3B cells were initially treated with NaB concentrations
of 0, 10, 15, and 20 µg/mL for 72 h in combination with
serum starvation in the last 24 h in order to determine the
effective treatment concentration for further experiments
(Figure 1A). According to the statistical analysis obtained
from 3 independent experiments with immunoblotting
study of total protein extracts with an antibody against the
ε-amino group of the lysine residue, significant decreases
of 29% and 19% were detected in the protein samples
prepared from cells treated with 15 µg/mL NaB compared
to other concentrations (Figures 1A and 1B).
3.2. Cellular NAD+/NADH ratio increases upon NaB
treatment
The cellular NAD+/NADH ratio was determined by
separately measuring NADt and NADH amounts in
cultured HEP3B cells harvested after treatment with 15 µg/
mL NaB for 72 h in combination with starvation. In order
to measure the NADH amounts, samples were heated at
60 °C to decompose NAD. NAD+/NADH ratios were then
calculated by subtracting NADH from NADt and dividing
the outcome by NADH. According to the results obtained
at 450 nm, 15 µg/mL NaB treatment decreased the NAD+
level by 14% and the NADH level by 53%. The cellular
NAD+/NADH ratio, however, doubled in cultured HEP3B
cells (P < 0.05) (Figure 2).
3.3. Mitochondrial proteins are deacetylated upon NaB
treatment
Mitochondria were isolated from HEP3B cells treated
with 15 µg/mL NaB and lysed for protein study.
Immunoblotting analysis of the samples separated by 10%
SDS-PAGE revealed a statistically significant decrease of
11% in mitochondrial proteome acetylation (P < 0.05)
(Figure 3A). The results obtained from the mitochondrial
HSP60 antibody signal and cytoplasmic GAPDH antibody
signal showed that the mitochondria of the 15 µg/mL NaBtreated samples and control samples were successfully
isolated (Figure 3B).
3.4. Protein synthesis decreases in OXPHOS machinery
upon NaB treatment
To analyze proteins related to oxidative phosphorylation
machinery, the amount of enzyme complexes involved
in this energy generation pathway was investigated upon
NaB treatment. According to the immunoblotting results
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Figure 1. NaB treatment decreases proteome acetylation. (A) Relative ratio of acetylation level to control (β-actin) in whole-cell
lysate proteins from HEP3B cells treated with NaB. (B) Acetylation and GAPDH signals of control and 15 µg/mL NaB treated whole
cell lysate proteins. *: P < 0.05.
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Figure 2. Cellular NAD+/NADH ratio is increased upon NaB
treatment. Intracellular NAD+/NADH ratios of cultured HEP3B
cells treated with NaB. *: P < 0.05.

following SDS-PAGE separation, a significant reduction
was observed in the OXPHOS complex subunits: 17%,
24%, 22%, 11%, and 13% in CI (complex I, NADH
dehydrogenase subunit NDUFB8), CII (complex II,
succinate dehydrogenase subunit SDHB), CIII (complex
III, cytochrome c oxidoreductase subunit UQCRC2), CIV
(complex IV, cytochrome c oxidase subunit MTCO1),
and CV (complex V, ATP synthase subunit ATPSA),
respectively (P < 0.05) (Figure 4A). Further analysis of
CIV confirmed that the synthesis of this mitochondrial
encoded complex subunit (MTCO1) decreased by 11%
when HSP60 antibody was used as the loading control
(Figure 4B).
3.5. NaB treatment reduced HEP3B cancer cell
proliferation
Cellular proliferation of HEP3B cells was determined in the
presence of the inner salt (MTS, 3-(4,5-dimethylthiazol-2yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2Htetrazolium) and the intermediate electron acceptor (PMS,
phenazine methosulfate). One thousand cells per well
were inoculated into a 96-well plate. The NaB treatment
was initiated after the day 1 measurement of cell viability.
Serum starvation in combination with the 15 µg/mL NaB
treatment was applied after the day 3 measurement of cell
viability. The results obtained over 4 days demonstrated
that cancer cell proliferation was reduced by 33%, 20%,
and 32% on days 2, 3, and 4, respectively, upon 15 µg/mL
NaB treatment (P < 0.05) (Figure 5A).
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Figure 3. Mitochondrial proteins are deacetylated upon NaB treatment. (A) Relative ratio of acetylation level to
control (HSP60) in mitochondrial proteins from HEP3B cells treated with NaB. (B) GAPDH and HSP60 signals of
control and 15 µg/mL NaB-treated whole-cell lysate (WCL), cytosolic fraction (CYTO), and mitochondrial (MITO)
proteins.

3.6. Cellular ROS levels are reduced upon NaB treatment
Cellular ROS activity was measured depending on the
activity of cellular esterases that deacetylate DCFDA to
a nonfluorescent compound, which is then oxidized to a
highly fluorescent compound, 2’,7’-dichlorofluorescein
(DCF), by ROS. The fluorescence intensity of samples was
measured at an excitation of 485 nm and an emission of
535 nm. According to the fluorescence data obtained by
a flow cytometer from 3 independent experiments, 15 µg/
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mL NaB treatment for 72 h in combination with 24 h of
starvation decreased cellular ROS levels by 73% in HEP3B
cells (P < 0.05) (Figure 5B).
3.7. NaB treatment enhanced SIRT3 deacetylase activity
SIRT3 enzymatic activity was determined by measuring
its deacetylase activity on a fluoro-substrate peptide added
to the reaction mixture. The fluorescence intensities of
samples were measured at an excitation of 360 nm and
an emission of 460 nm. Specific activity of SIRT3 was
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Figure 4. (A) Protein synthesis is decreased in OXPHOS machinery upon NaB treatment. Relative ratios of OXPHOS complex
enzyme levels to control (HSP60) in mitochondrial proteins from HEP3B cells treated with NaB. (B) Relative ratio of complex IV level
to control (HSP60) in mitochondrial proteins from HEP3B cells treated with 15 µg/mL NaB. *: P < 0.05.

calculated using the fluorescence intensity values obtained
during the initial 20 min of reaction. Data showed that
NaB significantly enhanced SIRT3 deacetylase activity by
31% in HEP3B cells treated with 15 µg/mL NaB, compared
to cells without treatment (P < 0.05) (Figure 5C).
4. Discussion
Most cancer cells are devoid of functional mitochondria.
They exhibit high ROS generation, reduced mitochondrial
enzyme activity, decreased levels of OXPHOS-derived
ATP, and increased acetylation of proteins regulating
metabolic gene regulation. These functional impairments
in mitochondria result in the Warburg effect, which is
demonstrated with enhanced glycolytic rate.
In this study, the impact of NaB-NAD+ interaction
on the activity of the stress-responsive mitochondrial
deacetylase SIRT3 was investigated. NaB was used to alter
the intracellular levels of NAD+ via chemical interaction.
This interaction, together with nutritional stress,
modulated SIRT3 deacetylase activity (Merksamer et al.,
2013). Given the importance of protein functioning in
coordinating metabolic pathways, the cellular energy hubs,
mitochondria, were targeted by this combined treatment
strategy. The aim was to reprogram the metabolism of
HEP3B human HCC cells by means of NaB treatment in
order to reverse the Warburg effect by restoring proper
mitochondrial function.
Immunoblotting analyses were performed to
investigate the acetylome of the proteins harvested from
HEP3B cells. Following an initial broad range analysis with

0–25 µg/mL NaB concentrations (Figure 1A), the applied
concentration was narrowed down to 15 µg/mL NaB
(Figure 1B). Immunoblotting analyses on 6 independent
sample groups revealed a significant decrease of 29% in
proteome acetylation of samples treated with 15 µg/mL
NaB (Figure 1A). Since the NaB treatment of 15 µg/mL was
considered to be an ideal concentration for the changes
in the acetylome of samples, experiments were further
carried out using this NaB concentration as the effective
dose (Figure 1B). Next, in order to confirm the interaction
between NaB and NAD+, the relative intracellular NAD+/
NADH ratio was investigated. Three independent analyses
showed that the intracellular NAD+/NADH ratio in HEP3B
cells increased by 100% upon treatment of cells with 15
µg/mL NaB combined with 24 h of starvation (Figure 2).
This result confirmed that the decrease in overall protein
acetylation observed in whole-cell lysate proteins was in
fact related to NaB-NAD+ interaction and brought up the
possibility of an improved cellular redox state achieved
through the functioning of metabolic proteins. Analyses
were directed towards the proteome of the cellular center
of energetic pathways, the mitochondria.
In order to analyze the mitochondrial proteome,
fractionation of mitochondria was initially performed
by employing a Dounce homogenizer. Immunoblotting
analysis of the mitochondrial proteome revealed a
significant decrease of 11% in the overall mitochondrial
protein acetylation (Figure 3A). Specific antibodies of the
mitochondrial protein HSP60 and the cytosolic protein
GAPDH served as controls of the isolation process (Figure

911

ÜSTÜNER and ÇİMEN / Turk J Biol

A
900

CON
NaB

Cell Viability (%)

800
700

*

600
500

*

400
300

*

200
100
0

1

2

3

DAYS

B

C

120

60
40

*
20

Relative SIRT3 Activity (%)

80

0

160

*

140

100

Relative ROS Level (%)

4

120
100
80
60
40
20

0

15

NaB Treatment (μg/mL)

0

0

15

NaB Treatment ( μg/mL)

Figure 5. (A) NaB treatment reduced HEP3B cancer cell proliferation. Percent cell viability measured through metabolic activity
of cultured HEP3B cells treated with 15 µg/mL NaB. (B) Cellular ROS levels are reduced upon NaB treatment. (C) Relative
SIRT3 activity is increased upon NaB treatment. *: P < 0.05.

3B). Thus, the NaB treatment was shown to be effective
in reducing the mitochondrial proteome acetylation, as
expected. This posttranslational alteration might have an
impact on the synthesis of mitochondrial proteins that
would further provide an insight into mitochondrial
biogenesis. Given their pivotal roles in energy generation,
the analyses of mitochondrial protein synthesis were
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preferentially carried out on the proteins involved in the
mitochondrial OXPHOS pathway. NDUFB8 (CI), SDHB
(CII), UQCRC2 (CIII), MTCOI (CIV), and ATPSA (CV),
the subunits of the OXPHOS complexes, were examined
by immunoblotting assay using the MitoProfile Total
OXPHOS Rodent Antibody Cocktail. According to the
analysis, a 17%, 24%, 22%, 11%, and 13% decrease was
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observed in the amounts of CI, CII, CIII, CIV, and CV
proteins, respectively (Figure 4A). The relative changes in
these subunits were calculated using HSP60 as a loading
control on the gels (Figure 4B). In addition, MTCOI is one
of the mitochondrial encoded subunits of mitochondrial
cytochrome c oxidase (CIV) and is synthesized by
mitochondrial ribosomes (Yang et al., 2010). The decrease
in the amount of MTCOI is in agreement with the finding
that mitochondrial ribosomes are acetylated and the
reduced acetylation level of ribosomal proteins results in a
lower rate of protein synthesis in the mitochondria (Yang
et al., 2010).
An overall reduction in the synthesis of proteins
responsible for ATP generation also indicates a reduction
in mitochondrial biogenesis. A decline in cellular
proliferation rate would be expected in light of this result,
which was investigated via cell viability assay. According
to the results obtained, a significant reduction of 33%,
20%, and 32% in cellular proliferation rates was observed
on days 2, 3, and 4 after treatment with 15 µg/mL NaB,
respectively (Figure 5A). Together with the results of
OXPHOS subunit synthesis, a decline in mitochondrial
biogenesis was confirmed.
This finding could indicate a functional restoration
of mitochondrial content in hepatoma cancer cells upon
NaB treatment by means of increasing the mitochondrial
quality via recycling of troubled mitochondria. For further
analyses, the level of ROS, a major factor contributing to
mitochondrial damage, was investigated in HEP3B cells.
Cellular ROS detection revealed a significant decrease
(73%) in the level of ROS in HEP3B cells treated with

15 µg/mL NaB (Figure 5B). This result verified that
mitochondrial functioning was indeed restored upon NaB
treatment, and mitochondrial content of HEP3B cells was
more resistant to free radical damage.
Lastly, in order to certify that the mitochondrial
deacetylase enzyme SIRT3 was in fact responsible for this
functional restoration and metabolic reprogramming, the
specific activity of SIRT3 was determined in the presence of
a protease (lysyl endopeptidase) that releases fluorophoreattached fragments from a substrate peptide. The intensity
of fluorescent signals coming from these fragments was
the measure of SIRT3 activity. The results showed that
SIRT3 deacetylase activity was significantly enhanced by
31% upon treatment with 15 µg/mL NaB (Figure 5C).
All together, these results indicate that NaB treatment
in combination with calorie restriction is effective in
inducing SIRT3 activation through NAD+ interaction. This
combined treatment strategy involving NaB treatment and
calorie restriction is shown to be successful in achieving
metabolic regulation through modifying mitochondrial
protein acetylation in human hepatocellular carcinoma.
For this reason, it is applicable to improve NaB-based
products to enhance the efficiency of treatments against
hepatocellular carcinoma.
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